Evidence map›Paper›PMID 40891458›Full record

ArticlePlant biotechnology journal2025

Aquilaria sinensis MYB-Like Transcription Factor AsMYB1 Promotes 2-(2-Phenylethyl)Chromone Biosynthesis Through Interacting With 14-3-3 Family Protein AsGRF1.

Xinyu Mi, Fanyuan Guan, Yuyan Zheng, Jing Fan, Hailing Qiu, Bowen Gao, Xiao Liu, Juan Wang, Jun Li, Shepo Shi and 2 more

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinyu Mi *Modern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Fanyuan Guan *School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Yuyan ZhengSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Jing FanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Hailing QiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Bowen GaoSchool of Pharmacy, Baotou Medical College Inner Mongolia, Baotou, People's Republic of China.
Xiao LiuModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0001-9701-0675
Juan WangModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Jun LiModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Shepo ShiModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xiaohui WangModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0003-3259-7588
Pengfei TuModern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Funding

Graduate Student Research Projects of Beijing University of Chinese Medicine ZJKT2025003National Natural Science Foundation of China 32170374National Natural Science Foundation of China 82360686Natural Science Foundation of Inner Mongolia Autonomous Region 2023MS08011
6 · The paper itself

Abstract

2-(2-Phenylethyl)chromones (PECs) are the primary constituents of agarwood, a valuable aromatic resin widely used in traditional oriental medicine and incense production, exhibiting diverse pharmacological activities. While we have previously reported a polyketide synthase (AsPECPS) playing a crucial role in the biosynthesis of PECs in agarwood, the intrinsic regulatory mechanisms underlying PEC biosynthesis remain largely elusive. Here, we successfully characterised a new 1R-subtype myeloblastosis (MYB) transcription factor (AsMYB1) from Aquilaria sinensis whose expression is significantly induced under salt treatment. Further overexpression, RNA interference (RNAi) and gene-editing experiments confirmed the positive regulatory role of AsMYB1 in PEC biosynthesis. AsMYB1 specifically bound to cis-elements in the promoter of AsPECPS to enhance its transcription, thereby promoting PEC accumulation under salt stress. A 14-3-3 family protein designated AsGRF1 was characterised to interact with AsMYB1 both in vivo and in vitro, and knockdown or knockout of AsGRF1 led to a dramatic reduction in AsPECPS expression and PECs' accumulation. Furthermore, AsGRF1 may positively facilitate AsMYB1-mediated activation of PEC production under salt stress by elevating AsPECPS expression through increasing the transcriptional activity, nuclear localisation and stability of AsMYB1. Our findings suggest that the AsGRF1-AsMYB1-AsPECPS module synergistically facilitates salt-induced PEC metabolism, inspiring potential biotechnological strategies to improve agarwood quality through metabolic engineering.

Indexed as

14-3-3 ProteinsChromonesPlant ProteinsThymelaeaceaeTranscription FactorsFlavonoidsGene Expression Regulation, Plant14-3-3 Proteins2-(2-phenylethyl)chromoneChromonesFlavonoidsPlant ProteinsTranscription Factors2‐(2‐phenylethyl)chromones (PECs)Aquilaria sinensisAsGRF1AsMYB1biosynthesisregulation

Identifiers

PMID40891458
PMCPMC12665066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.